Fund Card

Fund Card

Tata India Pharma & Healthcare Fund-Reg(G)

As on Nov-15-2019 change fund
8.99  up0.08 (0.92%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2015-20162016-20172017-20182018-2019
NAV in Rs (as on 29-Mar-2019)9.389.118.359.09
Net Assets(Rs Crores) (as on 29-Mar-2019) 76.37 80.88 133.13 179.56
Scheme Returns(%)(Absolute)-6.25-2.87-9.687.51
B'mark Returns(%)(Absolute)-16.34-4.73-20.438.42
Category Rank22/5952/5654/6224/73
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2019-2020-4.661.78NANA
2018-20192.446.80-4.444.15
2017-2018-4.38-6.159.58-6.86
2016-2017-0.321.99-10.176.42
2015-2016NANANA-6.55
Top 10 holdings
company (%)
Dr. Reddys Laboratories Ltd.14.67 
Sun Pharmaceutical Industries...11.63 
Divis Laboratories Ltd.10.14 
Lupin Ltd.9.01 
Abbott India Ltd.8.82 
Procter & Gamble Health Ltd.7.00 
Ipca Laboratories Ltd.6.38 
Apollo Hospitals Enterprise Ltd.5.30 
Alembic Pharmaceuticals Ltd.4.59 
Aurobindo Pharma Ltd.4.47 

Category

Sector Funds

Launch Date

28-Dec-15

Scheme Benchmark

NA

AUM ( in Cr.)

173.63

portfolio price to book value

NA

investing style?

Mid Growth

fund manager?

Sailesh Jain,Meeta Shetty

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.58

Alpha [%]

-0.03

Beta [%]

0.49

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs85.88
Hospital & Healthcare Services6.45
Miscellaneous2.81

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015173.630.273.193.311.570.30NANA-2.69BUYSIP
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,429.66-0.164.105.39-4.071.883.4914.4918.96BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005392.780.244.825.22-4.07-2.79-0.7511.1015.76BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999936.91-1.325.785.94-5.18-5.85-0.4713.1913.66BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018357.92-0.454.475.560.81NANANA3.60BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,339.10-0.305.174.95-0.60NANANA-0.30BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019170.53-3.131.791.89NANANANA2.30BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201933.170.294.695.99NANANANA2.60BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018235.17-0.226.677.90NANANANA5.40BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974